Eli Lilly Files 8-K Detailing Debt Offerings

Ticker: LLY · Form: 8-K · Filed: 2025-02-12T00:00:00.000Z

Sentiment: neutral

Topics: debt-offering, financing, capital-structure

Related Tickers: LLY

TL;DR

LLY just dropped an 8-K detailing a bunch of new debt notes with varying maturity dates and interest rates.

AI Summary

Eli Lilly and Company (LLY) filed an 8-K on February 12, 2025, reporting other events and financial statements. The filing details various debt issuances, including notes due in 2025, 2026, 2030, 2031, 2033, 2036, 2043, 2049, 2051, and 2061, with interest rates ranging from 1.625% to 6.77%.

Why It Matters

This filing indicates Eli Lilly is actively managing its capital structure through significant debt issuances, which could impact its financial leverage and future investment capacity.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of debt issuances and does not indicate any immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What is the total principal amount of the debt offerings disclosed in this 8-K?

The filing does not explicitly state the total principal amount of the debt offerings, but lists various notes with different maturity dates and interest rates.

What are the specific maturity dates for the notes issued by Eli Lilly?

The notes have maturity dates in 2025, 2026, 2030, 2031, 2033, 2036, 2043, 2049, 2051, and 2061.

What is the purpose of these debt issuances?

The filing does not specify the exact purpose of these debt issuances, but they are listed under 'Other Events' and relate to the company's financing activities.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted on February 12, 2025.

What is Eli Lilly's Standard Industrial Classification (SIC) code?

Eli Lilly's SIC code is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0001193125-25-025057.txt : 20250212 0001193125-25-025057.hdr.sgml : 20250212 20250212152848 ACCESSION NUMBER: 0001193125-25-025057 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 22 CONFORMED PERIOD OF REPORT: 20250210 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250212 DATE AS OF CHANGE: 20250212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 25614489 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 8-K 1 d868986d8k.htm 8-K 8-K ELI LILLY & Co false 0000059478 0000059478 2025-02-10 2025-02-10 0000059478 us-gaap:CommonClassAMember 2025-02-10 2025-02-10 0000059478 lly:A718NotesDueJune12025Member 2025-02-10 2025-02-10 0000059478 lly:A1.625NotesDueJune22026Member 2025-02-10 2025-02-10 0000059478 lly:A2.125NotesDueJune32030Member 2025-02-10 2025-02-10 0000059478 lly:A625Notesdue2031Member 2025-02-10 2025-02-10 0000059478 lly:A500NotesDue2033Member 2025-02-10 2025-02-10 0000059478 lly:A6.77NotesDueJanuary12036Member 2025-02-10 2025-02-10 0000059478 lly:A1625NotesDue2043Member 2025-02-10 2025-02-10 0000059478 lly:A1.700Notesdue2049Member 2025-02-10 2025-02-10 0000059478 lly:A1125NotesDue2051Member 2025-02-10 2025-02-10 0000059478 lly:A1375NotesDue2061Member 2025-02-10 2025-02-10     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 10, 2025     ELI LILLY AND COMPANY (Exact Name of Registrant as Specified in its Charter)       Indiana   001-06351   35-0470950 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   Lilly Corporate Center Indianapolis , Indiana (Address of Principal Executive Offices)   46285 (Zip Code) Registrant’s Telephone Number, Including Area Code: (317) 276-2000 Not Applicable (Former Name or Former Address, if Changed Since Last Report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2.):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock (no par value)   LLY   New York Stock Exchange 7 1/8% Notes due 2025   LLY25   New York Stock Exchange 1.625% Notes due 2026   LLY26   New York Stock Exchange 2.125% Notes due 2030   LLY30   New York Stock Exchange 0.625% Notes due 2031   LLY31   New York Stock Exchange 0.500% Notes due 2033   LLY33   New York Stock Exchange 6.77% Notes due 2036   LLY36   New York Stock Exchange 1.625% Notes due 2043   LLY43 &#

View on Read The Filing